Investor
Ideas #Potcasts, #Cannabis News and #Stocks on the Move; (CSE: $BHNG.C) (TSXV: $NDVA.V) (TSXV: $LIFT.V) (TSXV: $TBP.V) (TSXV: $FLWR.V)
Delta, Kelowna, BC, February 13, 2020 (Investorideas.com
Newswire) www.Investorideas.com, a global news source covering leading sectors
including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight
from thought leaders and experts.
Listen to the
podcast:
Read this in full
at https://www.investorideas.com/news/2020/cannabis-potcasts/02131BHNG-NDVA-LIFT-TBP-FLWR.asp
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com
"Potcast" featuring cannabis news, stocks to watch as well as
insights from thought leaders and experts.
In
today’s podcast we look at a few early announcements.
Bhang
Inc. (CSE: BHNG) (OTCQX: BHNGF), a global cannabis CPG brand
company with an extensive, award-winning portfolio of products, announced that its cannabis-infused milk and
dark chocolates are now available for sale in Canada through its joint venture
with Indiva Limited (TSXV:NDVA) (OTCQX:NDVAF).
Bhang’s chocolate
can be purchased in Ontario, Alberta and Saskatchewan and will soon be
available in Manitoba and Nova Scotia.
As previously
announced in April 2018, Indiva and Bhang have a 50/50 joint venture to produce
and distribute Bhang Chocolate. Through the joint venture, Indiva creates Bhang
Chocolate in its state-of-the-art facility based in London, Ontario. Each
chocolate contains 10 mg of tetrahydrocannabinol (THC) and comes from
sustainably sourced cacao. Chocolates are scored into four pieces, so they are
perfect for sharing. Looking ahead, Bhang and Indiva intend to bring
cannabidiol (CBD) chocolates to Canadian consumers later in the year.
“We’re fortunate to
have established partners like Indiva to help us provide Canadian consumers
with the highest quality of edibles available in the recently launched Cannabis
2.0 market,” said Bhang President & CEO Jamie Pearson. “Deloitte analysts estimate that the
Canadian market for edibles, extracts and topicals could be worth C$2.7 billion
annually, with cannabis edibles accounting for C$1.6 billion alone. We see
significant opportunity in the Canadian market and are proud to bring our
exceptional chocolate to our friends up north.”
In addition to its
Canada joint-venture, Bhang’s multi-state cannabis platform includes licensees
in Florida, Nevada, Michigan, New Mexico, Illinois and Ohio. The Company’s
hemp-derived CBD products are available throughout the U.S. in brick &
mortar stores and online as well as in Puerto Rico, Germany, Austria,
Switzerland, Poland, and the U.K.
In the decade since
Bhang was founded, the company has received dozens of top honors for its edible
cannabis and cannabidiol-based products. Most recently, Bhang won the Best Cannabis-Infused Chocolate Award at
WeedCon West 2019 as well as Best
Cannabis Chocolate in New Mexico from Dank Magazine. Other top edible
honors included numerous High Times Cannabis
Cup Best of Awards, and acknowledgments from a diverse range of
competitions such as the Medical Cup, Chalice Cup, Patients Choice and the 805
Cannabud Cup, among many others.
Bhang’s brand
portfolio of 100+ cannabis, hemp-derived CBD and non-cannabis products includes
an assortment of chocolate, tinctures, pre-roll straights, gum, capsules,
gummies as well as range of organic beverages and powders spanning the
lifestyle segment through its wholly owned subsidiary Red Ace Organics.
Lift & Co. (TSXV: LIFT) (OTCQB: LFCOF) announced key updates for Cohesion, the
Company’s cannabis consumer insights platform. Starting today, Cohesion clients
can build custom, real-time dashboards using more than 100 available dimensions
to better meet the specific needs of organizations of any size. Insights can be
easily shared across teams at all levels to align businesses to a single source
of truth.
“We are
at a pivotal moment where marketing dollars for cannabis companies need to go
further than they ever have,” said Matei Olaru, CEO of Lift & Co. “Cohesion
is a timely solution in today’s market that will accurately track sales, enable
custom consumer segmentation and deploy targeted digital marketing to these
segments all in one place. Today’s major release enables organizations of all
sizes and budgets to improve their marketing efficiency, impacting both
top-line and bottom-line performance.”
Cohesion
draws from Lift & Co.’s millions of cannabis consumer and budtender data
points, accumulated over the past five years through verified reviews, purchase
receipts and brand research, and on the Lift.co and CannSell platforms. Unlike
traditional CPG and cannabis data providers, Lift & Co.’s combination of
actively and passively collected behavioural data (e.g. purchases) and attitudinal
data (e.g. product sentiment) at a single source provides a 360-degree view for
consumer insights. To gain an even deeper competitive edge, Cohesion clients
can also compare their own brand to their competitors’ along each dataset.
Lift
& Co.’s data sources inform three primary dashboards on Cohesion:
●
Purchase
behaviour:
Sales tracking, market share, basket size and composition, consumer
demographics, and more.
● Product sentiment:
Detailed product review and rating insights (volumes and analysis), repeat
purchase intent, and more.
●
Brand
equity: Overall
brand awareness including sentiment, brand value, perception, and more.
"Leveraging
data is the best way consumer brands can get a competitive advantage but, too
often, too many resources are spent sourcing, stitching together and analyzing
the data just to deliver those insights to the business,” said Sean Copeland,
VP of Data, Lift & Co. “Cohesion will make any product or marketing cycle
more efficient by enabling the gathering of key consumer insights, advertising
directly to target audiences, and tracking the success of those campaigns on
one platform. The emergence of a major new industry has created new data
intelligence opportunities and we’re delivering on that with Cohesion.”
With
today’s release of Version 2, Cohesion clients can manipulate any combination
of metrics from these three primary datasets on their own dashboards,
personalized to their strategy, to answer common questions such as:
●
How did my most recent marketing campaign
elevate brand awareness?
● How does
market share currently break down by brand, and is my brand’s market share
trending up or down?
● How
likely are consumers to purchase my product(s)? How will this affect my top
line?
●
Who is my consumer and what else do they
buy?
More than
30 Canadian cannabis brands are on the Cohesion platform since it launched in
September 2019. Following the introduction of consumer purchase receipt
uploading to Lift & Co. in 2018, and the addition of high-value rewards
like travel contests, the Company has had an accelerated increase in data
volume with a 498% increase in total submitted receipts and 326% increase in
total reviews for the three-month period ended December 31, 2019 compared to
the previous year. This increased volume has resulted in improved accuracy on
Cohesion with a margin of error of +/- 5% at a 95% confidence level for the top
50 brands in Canada.
Also
launching in 2020 is Cohesion Segmentation - powered by Nielsen, which will
combine Lift & Co. cannabis data with Nielsen’s CPG consumer insights.
Brands will be able to identify custom consumer segments based on cannabis and
non-cannabis buyer trends, and track how they and their competitors’ brands
interact with those segments. Cohesion Segmentation will also include Adobe
Advertising Cloud’s DSP to seamlessly deliver programmatic, compliant digital
advertising to targeted consumers. This brings much-needed industry-standard
advertising solutions to cannabis, as well as the ability to track the results
of those campaigns on Cohesion dashboards. With these enhancements, the Company
estimates that Cohesion clients will be able to increase click-through-rates by
over 20% and reduce digital customer acquisition costs by as much as 30%.
Listen
to Investorideas recent podcast interview with Matei Olaru here.
Tetra
Bio Pharma Inc. (TSX-V:TBP) (OTCQB:TBPMF), a leader in cannabinoid-derived
drug discovery and development, announced it has signed a definitive
manufacturing agreement with Vitiprints LLC, for the commercial scale
production of CAUMZ™ and HCC011. This
agreement will further protect CAUMZ™ and HCC011 with four additional patents
on manufacturing know-how.
VITIPRINTS has
developed a proprietary and patented manufacturing system, which can be used by
Tetra to manufacture its CAUMZ™ drug on commercial scale. As part of the manufacturing agreement Tetra
has obtained a Vitiprints exclusive license to use this technology for
commercial manufacturing CAUMZ™ and HCC-011 at high speed and volume in a
manner that will permit it to be used in a vaporization system (CAUMZ™ kit). This proprietary technology will operate
under pharmaceutical GMP (Good Manufacturing Practices) regulations and will
ensure a "pill-to-pill" consistency that meets inhalation drug
standards.
In exchange of this
exclusive license Tetra will be required to make milestones and royalty payments
on CAUMZ™ sales. From a financial
standpoint this proprietary technology will allow Tetra to reduce it Cost of
Goods Sold (COGS) for CAUMZ™ by approximately 75% and will significantly
improve CAUMZ™ gross margin.
Vitiprints will
perform a thorough assessment of the Quantum Facility in Moncton next week with
an objective of implementing its technology in the spring for the production of
commercial batches. “The previous
technology used for the manufacturing process was excellent but unfortunately
it was limited by its maximal batch size capacity.” said Dr. Guy Chamberland,
Tetra Bio-Pharma’s CEO and Chief Regulatory Officer. “In a first phase of implementation, Tetra’s
production capacity will increase from 2,500 dosing capsules in a 3-day shift
to 100,000 CAUMZ™ dosage units in a single 8-hour shift. The second phase will involve a scale-up and
transfer of this proprietary technology to a Greater Montreal Pharmaceutical
facility.”
"Tetra is now
moving full speed into the implementation of it commercial manufacturing of its
key assets CAUMZ™ and HCC011. This
agreement provides Tetra with high speed and volume and flexibility to meet the
global demand for CAUMZ™ and HCC-011.
Tetra must manufacture batches of CAUMZ™ using its commercial
manufacturing process to complete the quality section of the New Drug
Application. It is very important for
Tetra to ensure it can meet the global demand of patients who are suffering
from cancer. Back orders are not an
option!” said Dr. Guy Chamberland, Tetra Bio-Pharma’s CEO and Chief Regulatory
Officer.
Also if you are
looking for a good overall presentation on the Cannabis space click the link here to see The Flower Corporation’s (TSXV: FLWR) 202 Investor Presentation which
includes a great graph of some of the top cannabis companies’ capital raises
versus expenses.
Investor ideas reminds all listeners to read our
disclaimers and disclosures on the
Investorideas.com website and this podcast is not an
endorsement to buy products or services or securities. Investors are reminded
all investment involves risk and possible loss of investment
Learn more about
our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
Investorideas.com
podcasts are also available on iTunes,
Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified
word mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that
Inspires Big Investing Ideas
Investorideas.com
is a recognized news source publishing third party news, research and original
financial content. Learn about investing in stocks and sector trends with our
news alerts, articles, podcasts and
videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water,
renewable energy and more. Investor Idea’s original branded content includes
the following podcasts and columns : Crypto Corner , Play
by Play sports and stock news column, Investor Ideas
Potcasts Cannabis News and Stocks on the Move podcast and
column, Cleantech
and Climate Change , Exploring
Mining the AI
Eye .
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other
news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations
of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of
cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Follow us on Cannabis Social Media
Contact Investorideas.com
800-665-0411
